Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic

被引:37
|
作者
Njouom, Richard [1 ]
Frost, Eric [2 ]
Deslandes, Sylvie [2 ]
Mamadou-Yaya, Fleurie [3 ]
Labbe, Annie-Claude [4 ]
Pouillot, Regis [5 ]
Mbelesso, Pascal [3 ]
Mbadingai, Sylvestre [3 ]
Rousset, Dominique [1 ]
Pepin, Jacques [2 ]
机构
[1] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon
[2] Univ Sherbrooke, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada
[3] Minist Hlth, Bangui, Cent Afr Republ
[4] Hop Maison Neuve Rosemont, Dept Microbiol, Montreal, PQ H1T 2M4, Canada
[5] Ctr Pasteur Cameroun, Lab Epidemiol, Yaounde, Cameroon
来源
关键词
IATROGENIC TRANSMISSION; EPIDEMIC; CAMEROON;
D O I
10.1099/vir.0.011981-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The molecular epidemiology of hepatitis C virus (HCV) in the Central African Republic (CAR) is poorly documented. Thus, we conducted phylogenetic analyses of NS5B gene sequences from 58 HCV-infected inhabitants of a remote area of south-west CAR, which indicated that 48 (82.8%) were infected with genotype 4 (HCV-4), five (8.6%) with genotype 2 and five (8.6%) with genotype 1. HCV-4 strains were highly heterogeneous, containing previously described subtypes 4k (48%), 4c (27%), 4r (4%), 4f (4%) and unclassified subtypes (17%). To estimate the epidemic history of these HCV-4 strains, an evolutionary analysis using the coalescent approach was used. The estimated date of the most recent common ancestor of the CAR HCV-4 strains was 1539 (95% confidence intervals, 1317-1697). They exhibited a rapid, exponential spread from 1935 to 1965, simultaneously with what was recently reported in neighbouring Cameroon and Gabon. The hypothesis of a massive iatrogenic transmission during interventions for the control of endemic tropical diseases is discussed.
引用
收藏
页码:2452 / 2456
页数:5
相关论文
共 50 条
  • [31] Enhanced virological responses in genotype 4 hepatitis C virus infection: a case control study
    Yan, K.
    George, J.
    Freiman, J.
    Craig, P.
    Hui, J.
    Zekry, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A308 - A308
  • [32] Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015
    Rossetti, B.
    Bai, F.
    Tavelli, A.
    Galli, M.
    Antinori, A.
    Castelli, F.
    Pellizzer, G.
    Cozzi-Lepri, A.
    Bonora, S.
    Monforte, A. d'Arminio
    Puoti, M.
    De Luca, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (04) : 422 - 427
  • [33] The hepatitis C virus epidemic in Cameroon:: Genetic evidence for rapid transmission between 1920 and 1960
    Njouom, Richard
    Nerrienet, Eric
    Dubois, Martine
    Lachenal, Guillaume
    Rousset, Dominique
    Vessiere, Aurelia
    Ayouba, Ahidjo
    Pasquier, Christophe
    Pouillot, Regis
    INFECTION GENETICS AND EVOLUTION, 2007, 7 (03) : 361 - 367
  • [34] HEPATITIS-C VIRUS GENOTYPE-4 IS HIGHLY PREVALENT IN CENTRAL-AFRICA (GABON)
    XU, LZ
    LARZUL, D
    DELAPORTE, E
    BRECHOT, C
    KREMSDORF, D
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 2393 - 2398
  • [35] Rapid fibrosis in hepatitis C virus genotype 4 (HCV4) patients after liver transplantation (LT)
    Wali, MH
    Heydtmann, M
    Harrison, R
    Hubscher, S
    Gunson, B
    Mutimer, D
    JOURNAL OF HEPATOLOGY, 2002, 36 : 43 - 43
  • [36] Viral load decline as predictor of treatment outcome in chronic hepatitis C virus genotype 4 infection
    Jessner, W
    Gschwantler, M
    Watkins-Riedel, T
    Steindl-Munda, P
    Mueller, C
    Hofmann, H
    Ferenci, P
    GASTROENTEROLOGY, 2002, 123 (01) : 70 - 70
  • [37] Sofosbuvir for Chronic Hepatitis C Virus Infection Genotype 1-4 in Patients Coinfected With HIV
    Rodriguez-Torres, Maribel
    Gaggar, Anuj
    Shen, Gong
    Kirby, Brian
    Svarovskaia, Evguenia
    Brainard, Diana
    Symonds, William T.
    McHutchison, John G.
    Gonzalez, Milagros
    Rodriguez-Orengo, Jose
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (05) : 543 - 549
  • [38] LEDIPASVIR/SOFOSBUVIR FIXED-DOSE COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS GENOTYPE 4 INFECTION
    Nehra, V.
    Tan, E. M.
    Rizza, S. A.
    Temesgen, Z.
    DRUGS OF TODAY, 2016, 52 (02) : 111 - 117
  • [40] Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
    Roulot, D.
    Bourcier, V.
    Grando, V.
    Deny, P.
    Baazia, Y.
    Fontaine, H.
    Bailly, F.
    Castera, L.
    De Ledinghen, V.
    Marcellin, P.
    Poupon, R.
    Bourliere, M.
    Zarski, J. P.
    Roudot-Thoraval, F.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (07) : 460 - 467